Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
CRBP Corbus Pharmaceuticals Holdings, Inc. daily Stock Chart
CRBP [NASD]
Corbus Pharmaceuticals Holdings, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-1.13 Insider Own0.50% Shs Outstand77.79M Perf Week13.29%
Market Cap404.51M Forward P/E- EPS next Y-1.40 Insider Trans13.59% Shs Float68.92M Perf Month7.22%
Income-71.50M PEG- EPS next Q-0.40 Inst Own43.70% Short Float21.23% Perf Quarter-7.80%
Sales36.10M P/S11.21 EPS this Y-14.50% Inst Trans-3.58% Short Ratio14.00 Perf Half Y2.56%
Book/sh0.10 P/B52.00 EPS next Y12.50% ROA-94.40% Target Price21.83 Perf Year-25.07%
Cash/sh0.41 P/C12.76 EPS next 5Y- ROE-227.80% 52W Range3.29 - 8.09 Perf YTD-4.76%
Dividend- P/FCF- EPS past 5Y-61.90% ROI- 52W High-35.72% Beta1.33
Dividend %- Quick Ratio1.10 Sales past 5Y- Gross Margin- 52W Low58.05% ATR0.50
Employees141 Current Ratio1.10 Sales Q/Q36.80% Oper. Margin- RSI (14)53.76 Volatility10.11% 11.70%
OptionableYes Debt/Eq0.13 EPS Q/Q-35.90% Profit Margin- Rel Volume0.69 Prev Close5.58
ShortableYes LT Debt/Eq0.00 EarningsMar 12 BMO Payout- Avg Volume1.05M Price5.20
Recom1.70 SMA2015.32% SMA50-6.88% SMA200-6.42% Volume718,488 Change-6.81%
Mar-26-20Initiated Nomura Buy $12
Apr-05-19Initiated Jefferies Buy
Mar-20-19Initiated Oppenheimer Outperform $28
Jan-11-19Reiterated Cantor Fitzgerald Overweight $36 → $38
Dec-26-18Initiated H.C. Wainwright Buy $24
Dec-07-18Initiated RBC Capital Mkts Outperform $23
Oct-24-18Initiated B. Riley FBR Buy $22
Jan-19-18Initiated Raymond James Outperform $24
Dec-14-17Reiterated Cantor Fitzgerald Overweight $24 → $28
Nov-08-17Reiterated Noble Financial Buy $16 → $20
Sep-29-17Resumed Noble Financial Buy $16
Mar-30-17Reiterated Cantor Fitzgerald Overweight $17 → $24
Nov-15-16Reiterated JMP Securities Mkt Outperform $9 → $20
Nov-11-16Reiterated Noble Financial Buy $19
Oct-05-16Initiated Cantor Fitzgerald Buy $17
Sep-08-15Initiated JMP Securities Mkt Outperform $6
Mar-14-20 08:52AM  Corbus Pharmaceuticals Holdings, Inc. Just Reported Earnings, And Analysts Cut Their Target Price Simply Wall St.
Mar-12-20 08:55AM  Corbus Pharmaceuticals (CRBP) Reports Q4 Loss, Lags Revenue Estimates Zacks -7.52%
07:05AM  Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2019 Financial Results GlobeNewswire
06:30AM  Corbus Pharmaceuticals Holdings, Inc. to Host Earnings Call ACCESSWIRE
Mar-10-20 08:05AM  Corbus Pharmaceuticals Announces Changes to its Board and Appointment of Pete Salzmann, M.D. as Independent Director GlobeNewswire +8.59%
07:14AM  Did Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Insiders Buy Up More Shares? Simply Wall St.
Mar-05-20 08:05AM  Corbus Pharmaceuticals to Report Fourth Quarter and Year-End 2019 Results on March 12, 2020 GlobeNewswire -5.87%
Mar-03-20 12:30PM  Earnings Preview: Corbus Pharmaceuticals (CRBP) Q4 Earnings Expected to Decline Zacks
Feb-11-20 04:01PM  Corbus Pharmaceuticals Announces Closing of $46 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares GlobeNewswire
Feb-10-20 08:58AM  Are Options Traders Betting on a Big Move in Corbus Pharmaceuticals (CRBP) Stock? Zacks
Feb-07-20 09:02AM  Corbus Pharmaceuticals Announces Pricing of Public Offering of Common Stock GlobeNewswire -7.87%
Feb-06-20 04:01PM  Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock GlobeNewswire
Jan-31-20 03:45PM  Top Marijuana Stocks on the NASDAQ Investopedia
Jan-25-20 08:09AM  Is Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) A Volatile Stock? Simply Wall St.
Dec-19-19 08:07AM  Does Corbus Pharmaceuticals Holdings, Inc.'s (NASDAQ:CRBP) CEO Pay Matter? Simply Wall St.
Dec-17-19 04:07PM  Hedge Funds Are Selling Corbus Pharmaceuticals Holdings Inc (CRBP) Insider Monkey
Dec-09-19 08:05AM  Corbus Pharmaceuticals to Host Expert Symposium on the Therapeutic Potential of Targeting the Endocannabinoid System GlobeNewswire
Nov-18-19 08:17AM  Corbus Pharmaceuticals Completes Enrollment of Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis GlobeNewswire
Nov-16-19 09:40PM  Edited Transcript of CRBP earnings conference call or presentation 7-Nov-19 1:30pm GMT Thomson Reuters StreetEvents
Nov-12-19 08:05AM  Corbus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference in London GlobeNewswire
07:20AM  We Think Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Can Afford To Drive Business Growth Simply Wall St.
Nov-11-19 08:05AM  Corbus Pharmaceuticals Updates Data from Lenabasum Open-Label Extension Studies in Systemic Sclerosis and Dermatomyositis at 2019 ACR Annual Meeting GlobeNewswire
Nov-07-19 11:15AM  Corbus Pharmaceuticals (CRBP) Reports Q3 Loss, Tops Revenue Estimates Zacks -7.96%
07:05AM  Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate Updates GlobeNewswire
Nov-05-19 01:00PM  3 Under-the-Radar Stocks Top Insiders Are Snapping Up TipRanks
Nov-04-19 08:05AM  Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2019 Operational and Financial Results on November 7, 2019 GlobeNewswire
Nov-01-19 12:08PM  Were Hedge Funds Right About Selling Corbus Pharmaceuticals (CRBP)? Insider Monkey
Oct-13-19 10:06AM  What Percentage Of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Do Insiders Own? Simply Wall St.
Oct-03-19 08:05AM  Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2019 ACR Annual Meeting GlobeNewswire
Oct-01-19 09:03AM  Marijuana stocks are oversold heres how to know when to buy them MarketWatch
Sep-13-19 07:21AM  Health Check: How Prudently Does Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Use Debt? Simply Wall St.
Aug-16-19 12:00AM  Edited Transcript of CRBP earnings conference call or presentation 8-Aug-19 12:30pm GMT Thomson Reuters StreetEvents
Aug-14-19 08:32AM  Have Insiders Been Buying Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares This Year? Simply Wall St. -6.07%
01:35AM  Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q2 2019 Earnings Call Transcript Motley Fool
Aug-12-19 12:15PM  Corbus Pharmaceuticals Holdings Inc (CRBP) COO Robert Paul Discordia Bought $87,900 of Shares GuruFocus.com
Aug-08-19 03:00PM  What You'll Want to Know About Corbus Pharmaceuticals' Q2 Results Motley Fool
11:15AM  Corbus Pharmaceuticals (CRBP) Q2 Earnings and Revenues Beat Estimates Zacks
07:05AM  Corbus Pharmaceuticals Reports 2019 Second Quarter Financial Results and Provides Clinical and Corporate Updates GlobeNewswire
Jul-12-19 01:32PM  How Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Can Impact Your Portfolio Volatility Simply Wall St.
Jul-10-19 05:51PM  Kadmon Initiates Dosing in Study for Systemic Sclerosis Drug Zacks
Jul-03-19 05:00PM  Horizons ETFs Rebalances Marijuana-Focused ETFs CNW Group
Jun-26-19 02:12PM  Money flows in 17 popular marijuana stocks show fewer short squeezes MarketWatch
Jun-17-19 08:05AM  Corbus Pharmaceuticals to Host 2019 R&D Day in New York City GlobeNewswire
Jun-13-19 07:04PM  Understanding Medical Cannabis vs. Recreational Cannabis Stocks Investopedia
Jun-12-19 08:05AM  Lenabasum Open-Label Extension Data to be Presented at EULAR 2019 Continue to Show a Favorable Safety Profile and Improvement in Efficacy Outcomes in Systemic Sclerosis and Dermatomyositis Phase 2 Studies GlobeNewswire
Jun-10-19 11:42PM  Edited Transcript of CRBP earnings conference call or presentation 9-May-19 12:30pm GMT Thomson Reuters StreetEvents
06:39PM  Robbins Arroyo LLP: Corbus Pharmaceuticals Holdings, Inc. (CRBP) Sued for Misleading Shareholders Business Wire
May-29-19 08:05AM  Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in June GlobeNewswire
May-28-19 08:05AM  Corbus Pharmaceuticals Announces Presentation of Six Abstracts at EULAR 2019 Annual Meeting GlobeNewswire
May-24-19 09:16AM  Does Corbus Pharmaceuticals Holdings, Inc.'s (NASDAQ:CRBP) CEO Pay Compare Well With Peers? Simply Wall St.
May-23-19 08:17AM  Is Corbus Pharmaceuticals a Buy Now? Motley Fool
May-15-19 08:05AM  Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in May GlobeNewswire
May-13-19 04:25PM  SHAREHOLDER ALERT: CRBP FSNN MWA AAPL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire -5.46%
03:00PM  CRBP, NIO & CORT Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Class Action GlobeNewswire
10:47AM  FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
09:51AM  CRBP, NIO & CORT Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Class Action ACCESSWIRE
09:32AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of NIO, CRBP, ARA and NTNX GlobeNewswire
May-10-19 03:55PM  3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE +8.21%
03:00PM  Bronstein, Gewirtz & Grossman, LLC Class Action Update: BPI, CRBP & NIO GlobeNewswire
02:40PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CRBP, ZGNX and BSX ACCESSWIRE
11:40AM  DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
10:33AM  Bronstein, Gewirtz & Grossman, LLC Class Action: BPI, CRBP & NIO ACCESSWIRE
09:05AM  SHAREHOLDER ALERT: CRBP MWA BSX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
May-09-19 04:52PM  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. GlobeNewswire -8.32%
04:20PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of USX, CRBP and MWA ACCESSWIRE
03:35PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Corbus Pharmaceuticals Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline CRBP GlobeNewswire
03:00PM  What You Need to Know About Corbus Pharmaceuticals' Q1 Earnings Update Motley Fool
01:23PM  Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q1 2019 Earnings Call Transcript Motley Fool
12:45PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CRBP, NTNX and S ACCESSWIRE
11:50AM  4-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
09:28AM  CLASS ACTION UPDATE for CRCM, CRBP, ARA and MWA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
09:15AM  Corbus Pharmaceuticals (CRBP) Reports Q1 Loss, Lags Revenue Estimates Zacks
08:04AM  Corbus Pharmaceuticals: 1Q Earnings Snapshot Associated Press
May-08-19 10:00PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bridgepoint, Corbus, and NIO and Encourages Investors to Contact the Firm GlobeNewswire
09:00PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of NIO, CRBP and ARA ACCESSWIRE
06:54PM  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. GlobeNewswire
03:35PM  SHAREHOLDER ALERT: EB CRBP NOK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
12:15PM  MAY 13 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:35AM  CLASS ACTION UPDATE for EB, CRBP and NOK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:32AM  Reminder Bronstein, Gewirtz & Grossman, LLC Class Action: BPI, CRBP & NIO ACCESSWIRE
May-07-19 07:50PM  CLASS ACTION UPDATE for NIO, CRBP and MBT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
05:55PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Corbus Pharmaceuticals Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline CRBP ACCESSWIRE
03:50PM  CLASS ACTION UPDATE for CRBP, ARA and NTNX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
01:45PM  6-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
May-06-19 05:10PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CORT, CRBP and BSX ACCESSWIRE
03:50PM  FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
02:10PM  SHAREHOLDER ALERT: HCSG CRBP BSX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:31AM  Bronstein, Gewirtz & Grossman, LLC Class Action Reminder: BPI, CRBP & NIO ACCESSWIRE
09:38AM  What's in the Cards for Corbus (CRBP) This Earnings Season? Zacks
May-03-19 09:05PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, USX and CRBP ACCESSWIRE +5.63%
08:21PM  INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
06:10PM  MAY 13 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:32AM  What's in Store for Sorrento (SRNE) This Earnings Season? Zacks
10:30AM  CLASS ACTION UPDATE for T, CNDT, CRBP and BSX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
May-02-19 08:03PM  CRBP CLASS ACTION REMINDER: Hagens Berman Reminds Corbus Pharmaceutical Holdings (CRBP) Investors of Securities Class Action, Encourages Investors with $50,000+ Losses to Contact the Firm GlobeNewswire
06:49PM  CRBP MAY 13th DEADLINE: Rosen Law Firm Reminds Corbus Pharmaceuticals Holdings, Inc. Investors of Important Deadline in Securities Class Action; Investors with Losses in Excess of $100K are Encouraged to Contact the Firm CRBP GlobeNewswire
06:30PM  SHAREHOLDER ALERT: BPI USX CRBP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
05:21PM  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Corbus Pharmaceuticals Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline CRBP GlobeNewswire
03:45PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BPI, USX and CRBP ACCESSWIRE
03:00PM  BPI, USX & CRBP Bronstein, Gewirtz & Grossman, LLC Reminder Shareholders of Class Action GlobeNewswire
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. Its lead product candidate is lenabasum, a synthetic oral endocannabinoid drug that is in Phase 3 clinical trial for the treatment of systemic sclerosis and dermatomyositis, and in Phase 2 clinical trial to treat systemic lupus erythematosus and cystic fibrosis. The company also has a license to develop, manufacture, and market CRB-4001, a 2nd generation peripherally-restricted, CB1 inverse agonist, which is in a preclinical stage to treat liver, lung, heart, and kidney fibrotic diseases. In addition, it has a strategic collaboration with Kaken Pharmaceutical Co., Ltd. for the development and commercialization of lenabasum in Japan. The company was founded in 2009 and is based in Norwood, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cohen YuvalChief Executive OfficerMar 17Buy3.494,30015,00771,090Mar 17 01:14 PM
Discordia Robert PaulChief Operating OfficerMar 17Buy3.542,84010,05435,490Mar 18 11:21 AM
White BarbaraChief Medical OfficerMar 17Buy3.6315,60656,650206,217Mar 18 10:37 AM
Millian Craig StuartChief Commercial OfficerMar 17Buy4.252,0008,50012,000Mar 18 01:18 PM
White BarbaraChief Medical OfficerNov 12Buy4.383,42414,992190,611Nov 13 10:00 AM
Cohen YuvalChief Executive OfficerNov 12Buy4.261,4306,09266,790Nov 12 01:02 PM
Millian Craig StuartChief Commercial OfficerNov 11Buy4.381,0004,38010,000Nov 12 11:07 AM
Discordia Robert PaulChief Operating OfficerNov 11Buy4.622,50011,55932,650Nov 12 09:57 AM
Millian Craig StuartChief Commercial OfficerAug 15Buy5.481,5008,2139,000Aug 16 09:50 AM
Millian Craig StuartChief Commercial OfficerAug 12Buy6.001,5009,0007,500Aug 13 09:48 AM
Cohen YuvalChief Executive OfficerAug 12Buy6.061,1757,11665,360Aug 12 10:37 AM
Discordia Robert PaulChief Operating OfficerAug 12Buy5.8615,00087,89430,150Aug 12 10:18 AM
White BarbaraChief Medical OfficerAug 12Buy6.101,6399,998187,187Aug 13 11:46 AM
White BarbaraChief Medical OfficerMay 17Buy7.201,38910,001185,548May 20 09:48 AM
Millian Craig StuartChief Commercial OfficerMay 14Buy7.231,0007,2276,000May 15 09:56 AM
Moran Sean F.Chief Financial OfficerMay 14Buy7.12100712349,610May 14 01:33 PM
Cohen YuvalChief Executive OfficerMay 13Buy6.999956,95564,185May 14 09:47 AM
open in yahoo | open in reuters | open in google